Vivos Therapeutics, Inc. VVOS
0.11 USD 0.00 (+1.28%)
At closeNov 4, 2026, 6:26 PM EST
0.11 0.00 +0.72%
After hours · Nov 4, 6:26 PM ET
0.11 Day range 0.1153
0.108 52-week range 2.59
- YTD
- -94.52%
- 1 year
- -95.29%
Financial health
Altman Z-Score
-11.29 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.0×
FY 2018 5y median -1.1× FY 2025
P/S 1.2×
FY 2018 5y median 1.2× FY 2025
P/B -14.0×
FY 2018 5y median 1.9× FY 2025
P/FCF -1.2×
FY 2018 5y median -1.2× FY 2025
EV/EBITDA -1.6×
FY 2018 5y median -1.3× FY 2025
EV/Sales 1.9×
FY 2018 5y median 1.1× FY 2025
FCF Yield -84.4%
FY 2018 5y median -84.0% FY 2025
Profitability
Gross Margin 60.4%
FY 2018 5y median 60.4% FY 2025
Operating Margin -114.1%
FY 2018 5y median -115.3% FY 2025
Net Margin -121.7%
FY 2018 5y median -120.2% FY 2025
ROE 1424.8%
FY 2018 5y median -140.0% FY 2025
ROIC -123.1%
FY 2018 5y median -123.1% FY 2025
ROA -84.4%
FY 2018 5y median -84.4% FY 2025
Growth (YoY)
Revenue 16.0%
FY 2018 FY 2025
Operating Income -78.1%
FY 2018 FY 2025
EPS (diluted) 7.2%
FY 2018 FY 2025
Free Cash Flow -32.8%
FY 2018 FY 2025
Financial Health
Current Ratio 0.2×
FY 2018 5y median 0.8× FY 2025
Quick Ratio 0.2×
FY 2018 5y median 0.8× FY 2025
Debt / Equity -9.1×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA -0.6×
FY 2018 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
